1. Home
  2. VOC vs BOLD Comparison

VOC vs BOLD Comparison

Compare VOC & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VOC

VOC Energy Trust Units of Beneficial Interest

HOLD

Current Price

$2.98

Market Cap

49.0M

Sector

Energy

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

N/A

Current Price

$1.26

Market Cap

28.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VOC
BOLD
Founded
2010
2018
Country
United States
United States
Employees
N/A
64
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
49.0M
28.4M
IPO Year
2011
2024

Fundamental Metrics

Financial Performance
Metric
VOC
BOLD
Price
$2.98
$1.26
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
65.5K
128.8K
Earning Date
01-01-0001
11-05-2025
Dividend Yield
20.76%
N/A
EPS Growth
N/A
N/A
EPS
0.51
N/A
Revenue
$9,783,812.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.44
$1.00
52 Week High
$4.39
$2.67

Technical Indicators

Market Signals
Indicator
VOC
BOLD
Relative Strength Index (RSI) 58.18 59.39
Support Level $2.90 $1.19
Resistance Level $3.07 $1.31
Average True Range (ATR) 0.08 0.08
MACD 0.02 0.00
Stochastic Oscillator 75.86 69.24

Price Performance

Historical Comparison
VOC
BOLD

About VOC VOC Energy Trust Units of Beneficial Interest

VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: